<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Trade Brains Features</provider_name><provider_url>https://tradebrains.in/features</provider_url><author_name>PTI News</author_name><author_url>https://tradebrains.in/features/author/ptinews/</author_url><title>'Continued pricing pressures in US, European markets to affect Indian pharma firms' profit margins'</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="Pcb0MW0UMI"&gt;&lt;a href="https://tradebrains.in/features/biz-indian-pharma-icra/"&gt;&#x2018;Continued pricing pressures in US, European markets to affect Indian pharma firms&#x2019; profit margins&#x2019;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://tradebrains.in/features/biz-indian-pharma-icra/embed/#?secret=Pcb0MW0UMI" width="600" height="338" title="&#x201C;&#x2018;Continued pricing pressures in US, European markets to affect Indian pharma firms&#x2019; profit margins&#x2019;&#x201D; &#x2014; Trade Brains Features" data-secret="Pcb0MW0UMI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://tradebrains.in/features/wp-content/uploads/2022/06/Pharma-1-Cover-Image.jpg</thumbnail_url><thumbnail_width>1280</thumbnail_width><thumbnail_height>854</thumbnail_height><description>Continued pricing pressures in the US and European markets coupled with regulatory overhang and cost inflation will affect profit margins of major Indian pharmaceutical firms, ratings agency ICRA said on Thursday. The revenues for a sample set of 16 Indian pharmaceutical firms, including the likes of Wockhardt, Torrent Pharmaceuticals, Pfizer, Abbott India, Cipla, Lupin, Sun [&hellip;]</description></oembed>
